Thursday, June 17, 2021

FOX NEWS: Novartis experimental prostate cancer drug gets FDA breakthrough designation


Novartis experimental prostate cancer drug gets FDA breakthrough designation



Novartis announced on Wednesday that the FDA granted Breakthrough Therapy designation to an experimental therapy that targets advanced castration-resistant prostate cancer.

via FOX NEWS https://ift.tt/3wEn1ge

No comments:

Post a Comment

Thanks for your comment reply within 24 hours